NASDAQ:BYSI - BeyondSpring Inc.
$15.47
 $0.35
+2.31%
4:00PM EDT
2019-04-18
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase II/III clinical trial for the prevention of non-docetaxel chemotherapy-induced severe, grade 4 neutropenia, and a Phase III clinical trial as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). Plinabulin has also entered in a Phase I/II clinical trials to investigate its therapeutic potential in combination with the immuno-oncology agent nivolumab.The Company's product, Plinabulin, is a marine derived small-molecule with a range of biological activities. Plinabulin targets cells in the tumor vasculature resulting in selective anti-tumor activity. Plinabulin has also demonstrated a range of immuno-stimulatory effects, including stimulating the maturation of dendritic cells, increasing cytokine secretion, down regulating inhibitory T-cells, and stimulating tumor-antigen-specific T-cell activation. The Company's BPI-002 program is based on an oral small molecule agent, which induces T-cell activation. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BYSI     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 13   203. 85   241. 91  
42 stocks rank:  4. 24 K 1. 44 K 1. 05 K
# analyst opinions:  3. 00   14. 51   13. 97  

quick ratio:  3. 95   5. 27   1. 81  
current ratio:  4. 36   5. 62   2. 25  

target price low:  35. 00   84. 80   115. 21  
target price avg:  15. 76   111. 51   137. 51  
target price high:  19. 10   135. 81   157. 84  
1-yr high:  33. 33   114. 23   138. 78  
last close:  15. 47   87. 66   116. 69  
50-day avg:  17. 43   95. 54   123. 44  
200-day avg:  20. 85   94. 25   121. 11  
1-yr low:  15. 12   72. 78   98. 34  
volume:  12. 03 K 4. 11 M 8. 07 M
50-day avg volume:  4. 03 K 2. 76 M 5. 02 M
200-day avg volume:  5. 31 K 2. 92 M 4. 59 M

1-day return:  2. 31 % -0. 41 % 0. 07 %
this week return:  -1. 78 % -5. 74 % -4. 11 %
12-wk return:  -14. 06 % 1. 61 % -0. 05 %
52-wk return:  -49. 67 % 3. 12 % 8. 78 %

enterprise value (EV):  336. 02 M 48. 94 B 114. 64 B
market cap:  355. 96 M 43. 07 B 104. 73 B
EBITDA:  -62. 31 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -5. 39   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -56. 85 M 2. 20 B 4. 20 B

shares outstanding:  23. 17 M 571. 70 M 1. 24 B
shares:  6. 52 M 571. 81 M 1. 23 B
shares short:  237. 31 K 10. 17 M 13. 00 M
shares short prior month:  229. 91 K 9. 54 M 17. 33 M
short ratio:  71. 00   5. 41   3. 28  
total cash/share:  0. 97   11. 14   9. 33  
total cash:  22. 43 M 6. 71 B 7. 15 B
free cash flow:  -17. 92 M 3. 58 B 2. 96 B
operating cash flow:  -40. 43 M 4. 15 B 4. 30 B

book value:  0. 86   12. 78   26. 92  
price/book:  18. 05   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  17. 84 % --- ---
1-yr mean volatility:  -0. 22 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 58   2. 40   4. 10  
forward EPS:  -1. 69   3. 97   7. 13  
P/E:  -6. 01   13. 63   22. 72  
forward P/E:  -9. 09   -15. 95   13. 99  
PE/G:  1. 33   -1. 65   -1. 32  
growth:  -4. 51 % 127. 12 % 29. 61 %
earnings high:  -0. 00   1. 00   1. 66  
earnings avg:  -0. 00   0. 77   1. 53  
earnings low:  -0. 00   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -101. 72 % -2. 75 % 4. 55 %
return on equity:  -179. 19 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  -0. 24   1. 25   0. 93  
sharpe (1yr):  -0. 96   0. 37   0. 70  

held % insiders:  77. 22 % 6. 39 % 3. 38 %
held % institutions:  1. 39 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : BYSI
.    + 1.358 =         1.358 :: INITIAL WEIGHT
.  + 120.376 =       121.734 :: inverse volume-to-price addition
.   + 44.422 =       166.156 :: spline projection addition
.    x 0.928 =       154.203 :: 13 weeks' performance factor
.     x 0.73 =       112.512 :: one-year gains+dividend factor
.    x 1.431 =       161.053 :: industry recommendation factor
.     x 0.99 =       159.415 :: return on assets factor
.    x 0.982 =       156.558 :: return on equity factor
.    x 2.776 =       434.538 :: current ratio factor
.    x 1.157 =       502.888 :: quick ratio factor
.    x 1.007 =       506.417 :: short ratio factor
.    x 2.334 =      1182.019 :: price-to-book factor
.    x 2.067 =      2443.188 :: P/E weight
.    x 0.931 =      2273.823 :: PE/G factor
.    x 1.418 =      3223.207 :: beta factor
.    x 0.964 =      3107.049 :: sharpe factor
.    x 2.279 =      7081.278 :: target low factor
.    x 1.045 =      7402.411 :: target mean factor
.    x 1.048 =      7760.918 :: target high factor
.     x 1.31 =     10165.932 :: industry 2-weeks return factor
.    x 0.957 =      9727.434 :: "drift" penalty 1 days ago
.    x 0.957 =      9310.995 :: "drift" penalty 2 days ago
.    x 0.994 =      9255.239 :: "drift" penalty 5 days ago
.     x 0.98 =      9071.323 :: overall "drift" factor
.    x 0.822 =      7452.767 :: largest single-day jump factor
.    x 0.585 =      4358.344 :: low price factor
.      x 1.0 =      4357.636 :: factor hist industry gain for week 16
.   cubeRoot =        16.334 :: reduced to standardize
.   - 19.767 =         0.133 :: add/subtract for performance
.                      0.133 :: FINAL WEIGHT for NASDAQ:BYSI


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org